Octreotide reduces the kinetic index, proliferating cell nuclear antigen–maximum proliferative index, in patients with colorectal cancer

This publication has 11 references indexed in Scilit:

• SMS 201.995 (Sandostatin) enhances in-vitro effects of 5-Fluorouracil in colorectal cancer
  European Journal of Surgical Oncology, 1995
• A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy
  British Journal of Cancer, 1995
• Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.
  Gut, 1994
• Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide
  British Journal of Surgery, 1994
• Octreotide inhibits development of hepatic metastases from a human colonic cancer cell line
  British Journal of Surgery, 1994
• Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
  British Journal of Surgery, 1993
• Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium.
  Gut, 1993
• Intracellular Gastrin in Human Gastrointestinal Tumor Cells
  JNCI Journal of the National Cancer Institute, 1991
• Somatostatin analogue rc‐160 inhibits the growth of transplanted colon cancer in rats
  International Journal of Cancer, 1991
• Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.
  Proceedings of the National Academy of Sciences, 1991